Answers are grounded in this paper and cite their sources.
Stroboscopic light stimulation (SLS) and psilocybin each induce altered states whose phenomenology and neurophysiology partly overlap, including posterior alpha-band changes and visual imagery. The two states engage the alpha band through different operations - pharmacological suppression under psilocybin and frequency-selective visual drive under SLS. We formalize their possible interaction for prediction and falsification. The framework proposes that, by relaxing the precision weighting of high-level cortical priors and, through 5-HT 2A activation, suppressing posterior alpha-band power, psilocybin creates a state in which an exogenous, frequency-controlled visual rhythm can modulate the perceiver’s experience. The thesis concerns precision rather than response amplitude. Because existing neuroimaging comes mostly from eyes-closed rest, where directional evidence is contested, the falsification does not depend on which sensory-inclusive model, Relaxed Beliefs Under Psychedelics (REBUS) or cortico-striatal-thalamo-cortical (CSTC), is correct. The framework predicts that, within a prespecified near-peak psilocin window, rhythmic SLS raises the Visionary Restructuralization dimension of the five-dimensional Altered States of Consciousness questionnaire (5D-ASC) relative to a luminance- and rate-matched arrhythmic control - an increase a precision framework predicts even if evoked amplitude does not rise. A complementary, report-independent endpoint, the intermodulation response to two-frequency stimulation, is proposed. State-dependence is tested as the drug-by-rhythmicity interaction in a 2 × 3 factorial design (placebo or psilocybin × rhythmic SLS, arrhythmic control, or no stimulation), with the sign of any interaction evaluated on a pre-declared scale. An adequately precise negative interaction would count against the central state-dependence prediction for the tested conditions. The framework organizes five axes around this prediction: titration of experiential intensity at fixed dose, content shaping through frequency specificity, modulation of difficult-experience phenomenology, testing whether resting-state signatures depend on sensory context, and individual-difference profiling of SLS responsiveness. The framework makes no claim of therapeutic enhancement. Its aim is mechanistic and methodological.
No takes yet. Share an insight, caveat, or question.
Żełabowski et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: